Upregulated level of TRAIL and soluble Fas ligand in IFN-beta treated relapsing-remitting multiple sclerosis patients

S Rinta, H Kuusisto, M Raunio, I Elovaara

Research output: Chapter in Book/Report/Conference proceedingConference contributionScientific

Original languageEnglish
Title of host publication23rd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS)
Publication statusPublished - 2007
Publication typeB3 Article in conference proceedings

Cite this